Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.58 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.58 |
| ▸ | F11 | P03951 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.48 |
| ▸ | MGLL | Q99685 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28429722 | 0.87 | LPL (0.52) | LPLLIPGF11CA2CA1 | |
| Ether SCHEMBL28233827 | 0.85 | LPL (0.55) | LPLLIPGF11CA2CA1 | |
| SCHEMBL9145073 | 0.80 | LPL (0.61) | LPLLIPGF11CA2CA1 | |
| SCHEMBL7283359 | 0.78 | TSHR (0.39) | LPLLIPGF11CA2CA1 | |
| SCHEMBL13667094 | 0.78 | LPL (0.64) | LPLLIPGF11CA2CA1 | |
| SCHEMBL890400 | 0.78 | LPL (0.73) | LPLLIPGF11CA2CA1 | |
| SCHEMBL204921 | 0.76 | ENPP2 (0.73) | LPLLIPGF11CA2CA1 | |
| SCHEMBL131361 | 0.76 | ALDH1A1 (0.67) | TSHRTRPA1ALDH1A1 | |
| SCHEMBL112402 | 0.76 | LPL (0.61) | LPLLIPGF11CA2CA1 | |
| SCHEMBL23406327 | 0.74 | LPL (0.58) | LPLLIPGF11CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 761 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122057086-A | Implanted microneedle anastomosis stent, and preparation method and application thereof | 浙江大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122005434-A | ROS responsive hydrogel eye drop preparation, preparation method thereof and application thereof in cornea disease treatment | 山西医科大学 | 2026-05-12 | — | — | CN | claimed |
| US-20250320313-A1 | METHOD FOR PREPARING POLY(IONIC LIQUID) (PIL)-FUNCTIONALIZED CELLULOSE CONDUCTIVE HYDROGEL | SHAANXI UNIV OF SCIENCE & TECHNOLOGY (CN) | 2025-10-16 | — | — | US | claimed |
| CN-120132050-A | ROS sensitive hydrogel composite polycaprolactone scaffold and preparation method and application thereof | 广西医科大学 | 2025-06-13 | — | — | CN | claimed |
| CN-120131953-A | Targeted nano-drug with sonodynamic activity, and preparation method and application thereof | 中山大学·深圳 | 2025-06-13 | — | — | CN | claimed |
| CN-120078705-A | Exosome-coated response type drug-loaded dendrimer nanogel system and preparation method and application thereof | 东华大学 | 2025-06-03 | — | — | CN | claimed |
| CN-116203006-B | Multichannel fluorescent array sensor and construction and use method thereof | 中国药科大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119684674-A | Glycoprotein imprinted polymer based on boric acid functional group-containing imidazole ionic liquid monomer, and preparation method and application thereof | 西京学院 | 2025-03-25 | — | — | CN | claimed |
| CN-119564885-A | Double-lock type viroid fluorescent nano probe for monitoring virus infection process, preparation method and application | 南开大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119455020-A | Multilayer composite drug-loaded nano motor and preparation method and application thereof | 南京鼓楼医院 | 2025-02-18 | — | — | CN | claimed |
| CN-108299485-B | Fluorescent probe for detecting hydrogen peroxide in living cells and preparation method and application thereof | 湖北大学 | 2020-05-12 | — | — | CN | claimed |
| CN-111097520-A | Covalent organic framework material loaded Pd catalyst and preparation method and application thereof | 中国科学院广州能源研究所 | 2020-05-05 | — | — | CN | claimed |
| CN-110882397-A | ATP (adenosine triphosphate) response type nano micelle, preparation method and application | 上海市肿瘤研究所 | 2020-03-17 | — | — | CN | claimed |
| CN-110642882-A | Fluorescent probe with hydrogen peroxide detection and photodynamic cancer cell killing activity as well as preparation method and application thereof | 内蒙古大学 | 2020-01-03 | — | — | CN | claimed |
| US-20180312617-A1 | A CATION POLYMER CAPABLE OF REMOVING POSITIVE CHARGES THROUGH OXIDATIVE RESPONSE, A PREPARATION METHOD AND APPLICATION | ZHEJIANG UNIVERSITY (CN) | 2018-11-01 | — | — | US | claimed |
| EP-1885714-B1 | PROCESS FOR THE PREPARATION OF 2-ALKYL-1-((2'-SUBSTITUTED-BIPHENYL-4-YL)METHYL)-IMIDAZOLE, DIHYDROIMIDAZOLE OR BENZIMIDAZOLE DERIVATIVES | LEK PHARMACEUTICALS (SI) | 2014-01-15 | — | — | EP | claimed |
| US-20090176849-A1 | Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives | LEK PHARMACEUTICALS, D.D. (SI) | 2009-07-09 | — | — | US | claimed |
| EP-1885714-A2 | PROCESS FOR THE PREPARATION OF 2-ALKYL-1-((2'-SUBSTITUTED-BIPHENYL-4-YL)METHYL)-IMIDAZOLE, DIHYDROIMIDAZOLE OR BENZIMIDAZOLE DERIVATIVES | LEK Pharmaceuticals D.D. (SI) | 2008-02-13 | — | — | EP | claimed |
| WO-2006125592-A2 | PROCESS FOR THE PREPARATION OF 2-ALKYL-1-((2'-SUBSTITUTED-BIPHENYL-4-YL)METHYL)-IMIDAZOLE, DIHYDROIMIDAZOLE OR BENZIMIDAZOLE DERIVATIVES | LEK PHARMACEUTICALS D.D. (SI) | 2006-11-30 | — | — | WO | claimed |
| EP-1009451-B1 | COMPOSITIONS AND THEIR USE TO PREVENT FORMATION OF ADHESIONS IN BIOLOGICAL TISSUES | CALIFORNIA INST OF TECHN (US) | 2003-10-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180312617-A1 | A CATION POLYMER CAPABLE OF REMOVING POSITIVE CHARGES THROUGH OXIDATIVE RESPONSE, A PREPARATION METHOD AND APPLICATION | PBRM1, SLC7A1, PHAX | LPL 4318/4885LIPG 4118/4885F11 3355/4885 |
| US-20090176849-A1 | Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives | AGTR1, AGTR2, REN | LPL 4261/4885LIPG 3937/4885F11 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.